Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Free Radical Biology & Medicine|March 11, 2022
Plasma-activated medium inhibits cancer stem cell-like properties and exhibits a synergistic effect in combination with cisplatin in ovarian cancerYoung Joo Lee, Sung Wook Kim, Min Hyung Jung, et al.
Experimental & Molecular Medicine|February 24, 2010
Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cellsEun Su Jeon, Soon Chul Heo, Il Hwan Lee, et al.
Oncotarget|August 5, 2016
Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancerEun Jin Seo, Dae Kyoung Kim, Il Ho Jang, et al.
Oncology Reports|September 3, 2010
High-throughput DNA hypermethylation profiling in different ovarian epithelial cancer subtypes using universal bead arrayMan Soo Yoon, Dong Soo Suh, Kyung Un Choi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 29, 2016
Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive ChemoradiotherapyDong Hyun Kim, Won Taek Kim, Jin Suk Bae, et al.
Stem Cells (Dayton, Ohio)|December 11, 2007
Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cellsEun Su Jeon, Hyun Jung Moon, Mi Jeong Lee, et al.
Molecules and Cells|July 30, 2021
TRIB2 Stimulates Cancer Stem-Like Properties through Activating the AKT-GSK3β-β-Catenin Signaling AxisDae Kyoung Kim, Yu Na Kim, Ye Eun Kim, et al.
Biochemical and Biophysical Research Communications|April 15, 2014
DDX4 (DEAD box polypeptide 4) colocalizes with cancer stem cell marker CD133 in ovarian cancersKi Hyung Kim, Yun-Jeong Kang, Jin-Ok Jo, et al.
Pageof 11